TITLE

Risk factors identified for adenovirus infection in HSCT patients

AUTHOR(S)
Richards, Cassandra A.
PUB. DATE
October 2012
SOURCE
Infectious Diseases in Children;Oct2012, Vol. 25 Issue 10, p11
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article presents information on research which examined the risk factors for adenovirus infection in children with hematopoietic stem cells transplant (HSCT).
ACCESSION #
87309990

 

Related Articles

  • Adenovirus Infections in Hematopoietic Stem Cell Transplant Recipients. Howard, Dianna S.; Phillips II, Gordon L.; Reece, Donna E.; Munn, Riat K.; Henslee-Downey, Jean; Pittard, Melissa; Barker, Matthew; Pomeroy, Claire // Clinical Infectious Diseases;12/1/1999, Vol. 29 Issue 6, p1494 

    Discusses an incidence of adenovirus infections among recipients of hematopoietic stem cell transplant (HSCT) from January to March 1997. Comparison between recipients of allogeneic and autologous stem cells; Correlation between the isolation of adenovirus from more than 1 site and risk for...

  • Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation. Ip, Winnie W. Y.; Qasim, Waseem // Advances in Hematology;2013, p1 

    Adenovirus (ADV) can cause significant morbidity and mortality in children following haematopoietic stem cell transplantation (HSCT), with an incidence of up to 27% and notable associated morbidity and mortality. T-cell depleted grafts and severe lymphopenia are major risk factors for the...

  • Risk factors identified for adenovirus infection in HSCT patients.  // Infectious Disease News;Oct2012, Vol. 25 Issue 10, p57 

    The article discusses research on adenovirus infection risk factors in pediatric hematopoietic stem cells transplant (HSCT) patients, conducted by Linda Feghoul and colleagues, presented at the 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held in California.

  • Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Zaia, J.A. // Bone Marrow Transplantation;4/15/2002, Vol. 29 Issue 8, p633 

    Addresses certain practical problems that commonly arise in the prevention and management of human cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation. Description of the persons who are at risk for CMV disease; Insight on the best diagnostic options; Recommendations.

  • Idiopathic hemophagocytic lymphohistiocytosis during pregnancy treated with steroids. Samra, Bachar; Yasmin, Mohamad; Arnaout, Sami; Azzi, Jacques // Hematology Reports;2015, Vol. 7 Issue 3, p70 

    Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe clinical syndrome characterized by a dysregulated hyperinflammatory immune response. The diagnosis of HLH during pregnancy is especially challenging due to the rarity of this condition. The highly variable clinical presentation,...

  • Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect. Choi, Jaebok; Cooper, Matthew L.; Alahmari, Bader; Ritchey, Julie; Collins, Lynne; Holt, Matthew; DiPersio, John F. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    We have recently reported that interferon gamma receptor deficient (IFNγR−/−) allogeneic donor T cells result in significantly less graft-versus-host disease (GvHD) than wild-type (WT) T cells, while maintaining an anti-leukemia or graft-versus-leukemia (GvL) effect after...

  • Penatmidine prevented pneumocystosis among pediatric HSCT patients.  // Infectious Disease News;May2013, Vol. 26 Issue 5, p28 

    The article discusses research which revealed that intravenous pentamidine is safe and effective for the prevention of Pneumocystis carinii pneumonia in pediatric hematopoietic stem cell transplantation patients, published in a 2013 issue of the "Pediatric Infectious Diseases Journal."

  • Comparison of Human Memory CD8 T Cell Responses to Adenoviral Early and Late Proteins in Peripheral Blood and Lymphoid Tissue. Joshi, Amita; Zhao, Biwei; Romanowski, Cara; Rosen, David; Flomenberg, Phyllis // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Treatment of invasive adenovirus (Ad) disease in hematopoietic stem cell transplant (SCT) recipients with capsid protein hexon-specific donor T cells is under investigation. We propose that cytotoxic T cells (CTLs) targeted to the late protein hexon may be inefficient in vivo because the early...

  • Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters. Toth, Karoly; Baoling Ying; Tollefson, Ann E.; Spencer, Jacqueline F.; Balakrishnan, Lata; Sagartz, John E.; Buller, Robert Mark L.; Wold, William S. M. // Viruses (1999-4915);2015, Vol. 7 Issue 3, p1409 

    Adenovirus infections of immunocompromised pediatric hematopoietic stem cell transplant patients can develop into serious and often deadly multi-organ disease. There are no drugs approved for adenovirus infections. Cidofovir (an analog of 2-deoxycytidine monophosphate) is used at times but it...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics